Amrize Q3 Revenue Up 2.2% to $3.77B; FY Revenue Guidance Cut to $12.2B-$12.4B
AMRZ is trading near its 52-week low of $35.785 (7.0% above the low).
Summary
Amrize grew Q3 revenue 2.2% to $3.77 billion but cut full-year revenue guidance to $12.2 billion-$12.4 billion on cost inflation and high rates, while completing its $1 billion buyback and declaring a $0.11 dividend.
Key Events · Earnings and Guidance · AMRZ
-
Q3 Revenue Up 2.2%, EBITDA Flat
Revenue rose 2.2% to $3,771 million and net income grew 3.3% to $558 million, but Adjusted EBITDA was up only 0.2% to $1,076 million and margin fell 60 basis points to 28.5%.
-
Full-Year Revenue Guidance Cut
FY2026 revenue guidance was lowered to $12.2 billion-$12.4 billion from the $12.5 billion-$12.7 billion range issued in August; Adjusted EBITDA is guided to $2.95 billion-$3.05 billion.
-
Building Envelope Margin Collapses
Building Envelope Segment Adjusted EBITDA fell 14.6% to $182 million with margin down 410 basis points to 19.6%; price-cost positivity there is now expected in 2027 rather than 2026.
-
$1 Billion Buyback Completed
The company completed its $1 billion share repurchase program on October 28, 2026, representing approximately 4% of share capital, after repurchasing $750 million in the first three quarters.
Analysis · AMRZ · Manufacturing
The headline is the outlook: Amrize cut full-year revenue guidance to $12.2 billion-$12.4 billion from the $12.5 billion-$12.7 billion range set in August, with Adjusted EBITDA now guided to $2.95 billion-$3.05 billion, as oil-driven cost inflation and elevated interest rates weigh on volumes. Third-quarter results were modestly mixed. Revenue rose 2.2% to $3,771 million and net income grew 3.3% to $558 million, but Adjusted EBITDA was essentially flat at $1,076 million and margin fell 60 basis points to 28.5%. Building Envelope is the weak spot: segment Adjusted EBITDA fell 14.6% to $182 million and margin dropped 410 basis points to 19.6%, and management pushed price-cost positivity there into 2027. Against that, the company completed its $1 billion buyback on October 28, 2026 (about 4% of share capital) and declared a $0.11 quarterly dividend payable November 18, 2026. Nine-month free cash flow was a $551 million use versus a $186 million use a year earlier, so the second half has to carry the cash generation. The filing also revises prior-period statements for an extended warranty misstatement and other immaterial items, which management says does not affect ongoing operations.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 39% of the 991 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMRZ was trading at $38.30 on NYSE in the Manufacturing sector, with a market capitalization of approximately $21.9B. The 52-week trading range was $35.79 to $65.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.